Pancreatic neuroendocrine tumour – Life with Disease

Go back

Pancreatic neuroendocrine tumors represent a rare but distinct form of cancer that develops in the hormone-producing cells of the pancreas, with outcomes and treatment approaches vastly different from the more common types of pancreatic cancer.

Understanding Your Outlook With Pancreatic Neuroendocrine Tumors

When someone receives a diagnosis of a pancreatic neuroendocrine tumor, understanding what lies ahead becomes crucial for both the patient and their loved ones. The outlook for people with this condition can vary significantly depending on several important factors, and it’s essential to approach this information with both realism and hope.[1]

Pancreatic neuroendocrine tumors, often called PNETs or islet cell tumors, behave very differently from the more common form of pancreatic cancer known as adenocarcinoma. While the name “pancreatic cancer” might initially sound frightening, PNETs generally grow much more slowly and respond better to treatment than their more aggressive counterparts. This fundamental difference in behavior means that many people with PNETs can live for years, and in some cases, the tumor can be cured completely with appropriate treatment.[2]

The prognosis depends heavily on whether the tumor is localized or has spread to other parts of the body. When a pancreatic neuroendocrine tumor is discovered early and remains confined to the pancreas, the outlook can be remarkably positive. Statistics show that the five-year survival rate for localized PNETs reaches approximately 95 percent, which means the vast majority of people whose tumors are caught early can expect to live at least five years beyond their diagnosis. This figure stands in stark contrast to other forms of pancreatic cancer, offering genuine reason for optimism when the disease is detected in its early stages.[21]

However, not all pancreatic neuroendocrine tumors are discovered before they have a chance to spread. When PNETs have metastasized to distant organs such as the liver, lungs, or bones, the five-year relative survival rate drops to approximately 23 percent. While this number is more sobering, it’s important to remember that survival rates are statistical averages based on large groups of patients. Individual experiences can vary widely, and advances in treatment continue to improve outcomes for people with advanced disease. Many patients with metastatic PNETs live significantly longer than five years, particularly with modern treatment approaches.[13]

The grade of the tumor also plays a significant role in determining prognosis. Tumor grade refers to how quickly or slowly the cancer cells are dividing and growing. Lower-grade tumors, where cells look more like healthy pancreatic cells and divide slowly, generally offer a better outlook than higher-grade tumors, where cells appear more abnormal and multiply rapidly. Most pancreatic neuroendocrine tumors are categorized as well-differentiated, meaning they grow slowly and tend to have better outcomes.[6]

Another factor that influences prognosis is whether the tumor is functional or nonfunctional. Functional tumors produce excess amounts of hormones, which can cause noticeable symptoms that lead to earlier detection. Nonfunctional tumors, on the other hand, don’t produce hormonal symptoms and may only be discovered when they grow large enough to cause physical discomfort or are found incidentally during imaging for another reason. The timing of discovery can significantly impact treatment options and overall outcomes.[3]

Approximately 10 percent of insulinomas, one type of functional pancreatic NET, turn out to be cancerous, while about 60 percent of gastrinomas are malignant. Glucagonomas are often cancerous, and VIPomas can also be malignant. Understanding which specific type of NET a person has helps doctors provide more accurate prognostic information tailored to that individual’s situation.[2]

⚠️ Important
Survival statistics represent averages from large groups of people and cannot predict what will happen to any individual patient. Your specific prognosis depends on many factors unique to you, including the exact characteristics of your tumor, your overall health, and how well you respond to treatment. Always discuss your personal situation with your healthcare team rather than relying solely on general statistics.

The biological behavior of individual pancreatic neuroendocrine tumors can be unpredictable. While many PNETs are indolent, meaning they grow slowly over many years, others may behave more aggressively. Higher tumor grade, the presence of lymph node involvement, liver metastasis, and larger tumor size generally indicate a less favorable prognosis. Yet even with these challenging features, many treatment options remain available that can control tumor growth and improve quality of life.[7]

It’s worth noting that the conservative estimate of PNET prevalence is approximately 25 to 30 per 100,000 people in the United States, and the incidence appears to be increasing due to improvements in diagnostic techniques and increased awareness among healthcare providers. This means more cases are being detected, including many that might have gone undiagnosed in the past, and more research is being conducted to develop better treatments.[7]

Natural Progression Without Treatment

Understanding how pancreatic neuroendocrine tumors develop and progress when left untreated helps patients appreciate the importance of medical intervention. While every tumor follows its own timeline, certain patterns emerge that help doctors and patients understand what might happen without treatment.[1]

Pancreatic neuroendocrine tumors originate in the hormone-making cells of the pancreas, specifically in clusters of cells called the islets of Langerhans. These specialized cells normally produce hormones like insulin and glucagon that regulate blood sugar, along with other hormones that control various digestive functions. When cells in these islets begin to grow abnormally, they form tumors that may either continue producing hormones in excess or stop producing them altogether.[3]

Most pancreatic NETs grow relatively slowly compared to other cancers. This indolent growth pattern means the tumor may be present in the body for years before causing any noticeable symptoms. During this silent period, the tumor gradually increases in size, potentially reaching several centimeters in diameter before being detected. This slow growth offers a window of opportunity for treatment, but it also means symptoms may not appear until the disease has progressed considerably.[7]

As a nonfunctional pancreatic NET grows larger, it begins to cause problems through physical effects rather than hormonal imbalances. The expanding mass may press against nearby organs, blood vessels, or nerves, leading to abdominal or back pain. The tumor may also obstruct the bile duct, which carries digestive fluid from the liver to the small intestine. This obstruction can cause jaundice, a yellowing of the skin and whites of the eyes, along with digestive problems.[1]

For functional tumors that produce excess hormones, the progression follows a different pattern. An insulinoma, which makes too much insulin, causes increasingly severe episodes of low blood sugar. These episodes can lead to confusion, weakness, sweating, and in severe cases, loss of consciousness. A gastrinoma produces excessive gastrin, leading to severe acid reflux, stomach ulcers, and chronic diarrhea that worsens over time. Glucagonomas cause a distinctive skin rash called necrolytic migratory erythema, along with diabetes and weight loss. VIPomas produce profuse watery diarrhea that can lead to dangerous dehydration and electrolyte imbalances.[5]

Without treatment, malignant pancreatic NETs have the potential to metastasize, meaning cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to establish new tumors in distant organs. The liver is the most common site of metastasis for pancreatic NETs, partly because blood from the pancreas flows directly to the liver through the portal vein. When NET cells reach the liver, they can form multiple tumors that gradually replace healthy liver tissue, compromising the organ’s ability to function.[2]

The lungs and bones are other potential sites where pancreatic NETs may spread. Lung metastases can interfere with breathing and cause persistent cough or chest pain. Bone metastases may lead to pain, fractures, or elevated calcium levels in the blood. Each new site of disease adds to the burden on the body and makes treatment more complex.[2]

The natural history of untreated pancreatic NETs varies considerably. Some tumors remain stable for extended periods, causing minimal symptoms and progressing very slowly. Others advance more rapidly, particularly those classified as higher grade or neuroendocrine carcinomas. In these aggressive cases, the tumor burden increases quickly, symptoms intensify, and the cancer may spread to multiple organ systems within months rather than years.[6]

As the tumor burden increases throughout the body, patients typically experience worsening constitutional symptoms. These include profound fatigue that doesn’t improve with rest, progressive weight loss despite adequate food intake, and a general sense of feeling unwell. The body’s metabolism becomes disrupted as the tumor consumes resources and interferes with normal organ function. Pain often becomes more severe and difficult to manage as tumors grow and put pressure on surrounding structures.[1]

Eventually, without intervention, the accumulation of tumor tissue and the loss of normal organ function can lead to life-threatening complications. The liver may become so infiltrated with tumor that it cannot perform its essential functions of filtering blood, producing proteins, and processing nutrients. The pancreas itself may be damaged enough that it cannot produce adequate digestive enzymes, leading to malnutrition. Hormonal imbalances from functional tumors can reach dangerous extremes, causing medical emergencies like severe hypoglycemia or life-threatening diarrhea.[14]

Possible Complications

Even with treatment, pancreatic neuroendocrine tumors can lead to various complications that affect different body systems. Understanding these potential problems helps patients and families prepare and respond appropriately when difficulties arise.[1]

The most significant complication occurs when cancerous pancreatic NETs metastasize to other organs. As mentioned, the liver represents the most common destination for these traveling cancer cells. Liver metastases can profoundly impact overall health because the liver performs hundreds of vital functions. When tumor nodules occupy large portions of the liver, they interfere with the organ’s ability to filter toxins from the blood, produce essential proteins for blood clotting, store energy, and metabolize medications. Patients with extensive liver involvement may develop jaundice, confusion from toxin buildup, increased bleeding tendency, and fluid accumulation in the abdomen called ascites.[2]

Functional pancreatic NETs create complications specific to the hormones they overproduce. Insulinomas can cause dangerous episodes of severe hypoglycemia, where blood sugar drops so low that the brain doesn’t receive enough glucose to function properly. These episodes may occur without warning and can lead to seizures, loss of consciousness, or even permanent brain damage if not promptly treated. Patients with insulinomas often need to eat frequently throughout the day and night to prevent these dangerous drops in blood sugar.[2]

Gastrinomas lead to a condition called Zollinger-Ellison syndrome, characterized by severe peptic ulcers and chronic diarrhea. The excess gastrin stimulates the stomach to produce extraordinary amounts of acid, which damages the lining of the stomach and small intestine. These ulcers can perforate, meaning they eat through the wall of the digestive tract, causing life-threatening internal bleeding or allowing digestive contents to spill into the abdominal cavity, triggering a serious infection called peritonitis.[11]

VIPomas cause massive watery diarrhea, sometimes exceeding several liters per day. This extreme fluid loss rapidly leads to dehydration and dangerous imbalances in blood electrolytes like potassium. Low potassium levels can cause muscle weakness, abnormal heart rhythms, and in severe cases, cardiac arrest. The diarrhea associated with VIPomas is so severe that it can prevent patients from leaving their homes and significantly impair their quality of life.[5]

Glucagonomas often cause a distinctive complication in the form of a skin rash called necrolytic migratory erythema. This painful, itchy rash typically appears on the face, abdomen, buttocks, and legs. The affected skin becomes red, develops blisters, and eventually the outer layer peels away. The rash is not only uncomfortable but can also become infected, requiring antibiotic treatment. Glucagonomas also cause diabetes because excess glucagon raises blood sugar levels, along with weight loss and an increased risk of blood clots forming in the legs or lungs.[5]

Somatostatinomas, though rare, can lead to a triad of problems: diabetes mellitus, gallstones, and fatty stools. The excess somatostatin interferes with multiple hormone systems, preventing proper regulation of blood sugar and digestive enzyme secretion. Patients may develop diabetes requiring insulin treatment, experience episodes of severe gallbladder pain from stones, and notice that their stools float and appear greasy due to undigested fat.[2]

Some patients with pancreatic NETs develop a group of symptoms called carcinoid syndrome, especially if the tumor has spread to the liver. This syndrome includes uncomfortable facial flushing, where the skin suddenly turns bright red and feels hot, along with wheezing, rapid heartbeat, and diarrhea. These episodes can be triggered by certain foods, alcohol, or stress. Over time, carcinoid syndrome can damage the heart valves, leading to heart failure if not properly managed.[2]

A rare but life-threatening complication is carcinoid crisis, which can occur during surgery, anesthesia, or other stressful situations. During a carcinoid crisis, massive amounts of hormones are suddenly released into the bloodstream, causing severe drops in blood pressure, difficulty breathing, rapid heart rate, and extreme flushing. This medical emergency requires immediate intensive treatment to stabilize blood pressure and heart function.[5]

The pancreatic tumor itself can cause complications by obstructing nearby structures. A tumor in the head of the pancreas may compress the common bile duct, preventing bile from reaching the intestines. This obstruction causes jaundice, itching, dark urine, and pale stools. It can also lead to infection in the blocked bile duct system, a serious condition called cholangitis that requires urgent medical intervention.[1]

As tumors grow larger, they may invade nearby blood vessels. Involvement of major vessels like the portal vein or superior mesenteric artery can complicate surgical removal and may cause problems with blood flow to the intestines or liver. In some cases, the tumor may erode into blood vessels and cause internal bleeding.[7]

Nutritional complications frequently develop in patients with pancreatic NETs. The pancreas produces enzymes essential for digesting food and absorbing nutrients. When tumors damage the pancreas or when portions of the pancreas are removed during surgery, patients may not produce enough digestive enzymes. This deficiency leads to difficulty absorbing fats, proteins, and fat-soluble vitamins, resulting in weight loss, diarrhea, and nutritional deficiencies. Patients may require pancreatic enzyme replacement therapy, where they take supplemental enzymes with meals to aid digestion.[18]

Bone metastases from pancreatic NETs can weaken the skeletal structure, making bones prone to fractures even with minor trauma. These metastases often cause persistent pain that requires strong medications for relief. When tumor cells in bone break down bone tissue, they release calcium into the bloodstream, potentially causing high blood calcium levels. This condition, called hypercalcemia, leads to confusion, kidney problems, irregular heartbeat, and severe constipation.[14]

Impact on Daily Life

Living with a pancreatic neuroendocrine tumor affects virtually every aspect of a person’s daily existence, from physical capabilities to emotional well-being, social relationships, work life, and leisure activities. Understanding these impacts helps patients and families adjust expectations and find ways to maintain the best possible quality of life.[16]

Physical limitations often become one of the most noticeable effects of pancreatic NETs. Many patients experience profound fatigue that differs from normal tiredness. This cancer-related fatigue doesn’t improve with rest and can make even simple tasks like showering, preparing meals, or walking short distances feel exhausting. The fatigue may result from the tumor itself, from the body’s immune response to cancer, or from treatments like chemotherapy. Learning to pace activities, taking frequent rest breaks, and prioritizing essential tasks become necessary strategies for managing limited energy.[1]

Digestive symptoms significantly disrupt daily routines for many patients with pancreatic NETs. Those with functional tumors that cause diarrhea may need to plan their lives around bathroom access, which can make leaving home anxiety-provoking. Severe diarrhea can lead to accidents that are embarrassing and distressing. Patients often become reluctant to eat in restaurants or attend social gatherings where they might not have easy access to a bathroom. Some people find themselves unable to work outside the home or must arrange their workspace to be near restroom facilities.[2]

Pain, whether from the tumor pressing on nearby organs or from metastases in bones or other sites, can make it difficult to sleep, work, or engage in activities that once brought joy. Chronic pain affects concentration, mood, and the ability to interact positively with others. Finding effective pain management becomes crucial not just for physical comfort but for maintaining mental health and social connections.[1]

Eating, which should be a source of pleasure and social connection, becomes complicated for many patients with pancreatic NETs. Those with carcinoid syndrome must avoid foods that trigger flushing episodes, including aged cheeses, cured meats, fermented foods, chocolate, and alcohol. This means declining foods at social gatherings, explaining dietary restrictions repeatedly, and sometimes feeling left out when others are enjoying meals freely. Some patients experience early satiety, feeling full after only a few bites, which makes maintaining adequate nutrition challenging. Others deal with nausea that makes food unappealing or painful abdominal symptoms that worsen with eating.[19]

For patients with insulinomas, the constant need to prevent hypoglycemia means eating frequently throughout the day and night, carrying emergency snacks everywhere, and remaining vigilant for warning signs of dropping blood sugar. This hypervigilance creates stress and interrupts sleep when midnight snacks become necessary to prevent dangerous blood sugar crashes.[14]

The emotional impact of living with a pancreatic NET cannot be overstated. Fear about the future, uncertainty about prognosis, and worry about how the disease will progress create ongoing anxiety. Many patients experience feelings that alternate between hope and despair, especially around the time of scans or doctor appointments when they’ll learn whether the tumor is growing or treatment is working. This emotional rollercoaster is exhausting in itself.[16]

Depression commonly affects people living with cancer. The combination of physical limitations, changed appearance, inability to do things one used to enjoy, and existential concerns about mortality can lead to persistent sadness, loss of interest in activities, changes in sleep patterns, and feelings of hopelessness. Recognizing and treating depression is essential because it not only affects quality of life but can also impact how well patients adhere to treatment plans.[16]

Social relationships often change when someone has a pancreatic NET. Some friends and family members may not know how to respond to the diagnosis and pull away, leaving patients feeling isolated precisely when they need support most. Others may become overly solicitous or treat the patient as fragile, which can feel infantilizing and frustrating. Patients themselves may withdraw from social activities due to fatigue, symptoms, or not wanting to burden others with their health problems.[16]

Intimate relationships face particular challenges. Physical symptoms, fatigue, changes in body image from weight loss or surgical scars, and the emotional burden of illness can all affect sexual desire and function. Partners may be afraid of causing pain or may themselves be dealing with fear and grief about the diagnosis. Open communication becomes essential, yet many couples find it difficult to talk about these sensitive issues.[16]

Work life often requires significant adjustments. Some patients can continue working throughout treatment, while others need to reduce their hours, take medical leave, or stop working entirely. Financial concerns about lost income, insurance coverage, and mounting medical bills add another layer of stress. Even for those who continue working, taking time off for frequent medical appointments, managing symptoms at work, and dealing with cognitive changes from treatment can be challenging. Some patients face difficult decisions about whether and when to disclose their diagnosis to employers and colleagues.[17]

Hobbies and recreational activities may need to be modified or abandoned. Someone who loved hiking may find they no longer have the stamina for long trails. A gardener may lack the physical strength for heavy digging. A person who enjoyed traveling may feel constrained by the need to be near their medical team or worried about symptoms occurring far from home. Finding adapted versions of beloved activities or discovering new pursuits that fit current capabilities helps maintain a sense of identity and purpose.[20]

⚠️ Important
While pancreatic NETs significantly impact daily life, many patients find ways to adapt and maintain good quality of life. Regular, gentle exercise can help combat fatigue and improve mood. Support groups connect patients with others facing similar challenges. Mental health professionals can provide tools for managing anxiety and depression. Nutritionists can help optimize eating strategies. Don’t hesitate to ask your healthcare team for referrals to these supportive services.

Many patients report feeling like they’re living in two worlds simultaneously: the world of the well, where they try to maintain normalcy and focus on things other than cancer, and the world of illness, filled with medical appointments, treatments, symptom management, and constant awareness of their disease. Balancing these two realities requires ongoing psychological work and support from healthcare providers, family, and friends.[16]

Despite these challenges, many people with pancreatic NETs find meaning and even unexpected positives in their experience. Some report that facing mortality clarifies priorities and helps them focus on what truly matters. Relationships may deepen as people learn to express love and appreciation more openly. Small pleasures and everyday moments can take on new significance. While no one would choose to have cancer, many patients develop resilience and coping skills they didn’t know they possessed.[20]

Practical strategies can help manage the impact on daily life. Keeping a symptom diary helps identify triggers and patterns. Planning activities during times of day when energy is typically highest maximizes functioning. Building in extra time for tasks reduces stress when fatigue slows things down. Accepting help from others, even though it may feel uncomfortable, allows patients to conserve energy for priorities. Using assistive devices or making home modifications to reduce physical demands can preserve independence.[17]

Support for Family Members

When someone receives a diagnosis of pancreatic neuroendocrine tumor, the entire family is affected. Family members and loved ones play a crucial role not only in providing emotional support but also in helping patients navigate the complex world of medical treatment, including participation in clinical trials.[17]

Understanding what pancreatic NETs are and how they differ from other cancers is the first step family members can take to provide effective support. Learning that PNETs generally grow more slowly and often have better outcomes than other pancreatic cancers can help family members maintain hope while remaining realistic. Reading reliable information from medical centers and cancer organizations helps families understand what their loved one is facing and prepares them to be informed advocates and supporters.[3]

Clinical trials represent an important treatment option for many patients with pancreatic NETs. These research studies test new treatments or new combinations of existing treatments to determine if they’re safe and effective. For patients with pancreatic NETs, clinical trials may offer access to promising therapies not yet available through standard care. However, finding appropriate trials, understanding what participation involves, and deciding whether to enroll can feel overwhelming. This is where family support becomes invaluable.[3]

Family members can help research clinical trials that might be suitable for their loved one. Numerous online databases list active trials, including the website at ClinicalTrials.gov, which is maintained by the National Institutes of Health. Searching for pancreatic neuroendocrine tumor trials allows families to see what studies are recruiting participants, what the entry requirements are, where the trials are located, and what treatments are being tested. Major cancer centers like MD Anderson, Mayo Clinic, and others often list their own clinical trials on their websites.[4]

Understanding the types of clinical trials available helps families have informed conversations with the medical team. Phase I trials test new treatments in small groups of people for the first time to evaluate safety and appropriate dosing. Phase II trials involve larger groups and focus on whether the treatment works for specific cancer types. Phase III trials compare new treatments against standard treatments in even larger groups to determine which approach is better. Knowing these distinctions helps families understand what questions to ask about specific trials.[9]

When a potentially suitable trial is identified, family members can help compile questions to ask the research team. Important questions include: What is the purpose of this trial? What treatment will be provided, and how does it differ from standard treatment? What are the potential benefits and risks? What tests and procedures are involved? How often will visits be required? Will there be costs, or does the trial cover expenses? How long will participation last? Can the patient stop participating if they wish?[3]

Practical support around clinical trial participation is equally important. Trials often require frequent visits to the medical center, sometimes weekly or even more often during certain phases. Family members can help with transportation to and from appointments, especially if the trial is at a center far from home. They can accompany the patient to appointments, help take notes during discussions with researchers, and provide a second set of ears when complex information is being presented. Stress and anxiety can make it difficult for patients to absorb and remember everything they’re told, so having a family member present to help recall the information is valuable.[21]

Emotional support throughout the decision-making process about clinical trial participation is crucial. Patients may feel uncertain about enrolling, worried about potential side effects, or anxious about receiving a placebo in trials that include one. Family members can listen to these concerns without judgment, help weigh the pros and cons, but ultimately support whatever decision the patient makes. It’s the patient’s body and life, and they must feel comfortable with their choice.[16]

If the patient enrolls in a clinical trial, family members can help track symptoms and side effects. Trials typically require detailed reporting of any problems that arise, and keeping good records helps ensure accurate reporting. Family members might notice changes in the patient’s condition that the patient themselves doesn’t recognize, providing valuable information to the research team.[17]

Beyond clinical trials, family members support their loved ones in countless other ways. Accompanying patients to regular medical appointments, helping manage medications, preparing foods that are easy to eat and align with dietary restrictions, taking over household tasks that have become too difficult, and simply being present provide immeasurable value. Sometimes the most important support is just sitting quietly together, offering companionship without needing to fix anything.[17]

Family members must also remember to care for themselves. Caregiver burnout is real and can lead to physical and emotional exhaustion. Taking breaks, maintaining their own health appointments, staying connected with friends, and seeking their own counseling or support groups for cancer caregivers helps family members sustain their ability to provide support over the long term.[17]

Open communication within the family is essential. Patients need to feel they can express fears, frustrations, and needs without burdening loved ones, while family members need to be able to share their own concerns and limitations. Regular family meetings where everyone can speak honestly about how they’re doing and what they need can prevent misunderstandings and resentment from building up.[16]

Children and teenagers in the family deserve age-appropriate explanations about what’s happening. Shielding young people from the reality of a parent’s or grandparent’s illness often backfires, as they sense something is wrong and imagine scenarios that may be worse than reality. Honest, simple explanations that answer their questions and reassure them that they’ll be cared for no matter what happens helps reduce anxiety and allows them to provide their own forms of support.[17]

Financial concerns often weigh heavily on families dealing with cancer. Family members can help by researching financial assistance programs, communicating with insurance companies about coverage questions, and helping the patient understand medical bills. Some hospitals have financial counselors who can suggest resources for patients struggling with costs. Organizations like the Pancreatic Cancer Action Network and others may have programs or information about financial assistance.[17]

Advance care planning, while difficult to discuss, is an important conversation families should have. Understanding the patient’s wishes regarding medical care if they become unable to make decisions themselves, discussing goals of care, and completing advance directive documents ensures that the patient’s preferences will be respected. Family members can help facilitate these conversations and ensure documents are properly completed and available to medical providers when needed.[16]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Lanreotide – A somatostatin analog that blocks growth hormones that feed slow-developing neuroendocrine tumors, typically given as monthly injections
  • CABOMETYX® (cabozantinib) – A targeted therapy approved for adults with well-differentiated pancreatic neuroendocrine tumors who have received previous treatment, are ineligible for surgery, and whose cancer has progressed

Ongoing Clinical Trials on Pancreatic neuroendocrine tumour

  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Belgium The Netherlands

References

https://www.mayoclinic.org/diseases-conditions/pancreatic-neuroendocrine-tumors/symptoms-causes/syc-20352489

https://my.clevelandclinic.org/health/diseases/21970-pancreatic-neuroendocrine-tumors

https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq

https://www.mdanderson.org/cancer-types/pancreatic-cancer/pancreatic-neuroendocrine-tumors.html

https://en.wikipedia.org/wiki/Pancreatic_neuroendocrine_tumor

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/types/pancreatic-nets

https://pmc.ncbi.nlm.nih.gov/articles/PMC3845620/

https://www.mayoclinic.org/diseases-conditions/pancreatic-neuroendocrine-tumors/diagnosis-treatment/drc-20475299

https://pmc.ncbi.nlm.nih.gov/articles/PMC6628351/

https://www.cancer.org/cancer/types/pancreatic-neuroendocrine-tumor/treating.html

https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq

https://www.mdanderson.org/cancer-types/pancreatic-cancer/pancreatic-neuroendocrine-tumors.html

https://pancan.org/news/fda-approves-new-treatment-for-pnets-what-you-need-to-know/

https://my.clevelandclinic.org/health/diseases/21970-pancreatic-neuroendocrine-tumors

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/options

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/living-with/coping

https://www.cancer.org/cancer/types/pancreatic-neuroendocrine-tumor/after-treatment/follow-up.html

https://netrf.org/old-for-patients/living-with-nets/nutrition/

https://www.webmd.com/cancer/neuroendocrine-tumors-feel-better

https://www.uchicagomedicine.org/forefront/cancer-articles/2023/september/pancreatic-nets-patient-chris-meyer

https://www.everydayhealth.com/pancreatic-cancer/ways-to-prep-for-pancreatic-neuroendocrine-cancer-treatment/

FAQ

Is a pancreatic neuroendocrine tumor the same as regular pancreatic cancer?

No, pancreatic neuroendocrine tumors are very different from the more common type of pancreatic cancer called adenocarcinoma. PNETs develop in the hormone-producing cells of the pancreas and generally grow much more slowly, respond better to treatment, and have significantly better survival rates than adenocarcinomas.

Can pancreatic neuroendocrine tumors be cured?

Yes, many pancreatic NETs can be cured, especially when discovered early and confined to the pancreas. Surgery to remove the tumor offers the best chance for cure. The five-year survival rate for localized PNETs is approximately 95 percent, meaning most people with early-stage tumors survive at least five years and many are completely cured.

What causes pancreatic neuroendocrine tumors?

Researchers don’t know the exact cause of most pancreatic NETs. Some cases occur in people with inherited genetic conditions like multiple endocrine neoplasia type 1 (MEN1), which affects about 5 to 10 percent of people with insulinomas or glucagonomas. However, most pancreatic NETs appear to develop sporadically without a clear hereditary pattern.

What are the warning signs of a pancreatic neuroendocrine tumor?

Symptoms vary depending on whether the tumor produces excess hormones. Common signs include severe acid reflux, diarrhea, fatigue, unexplained weight loss, nausea, abdominal pain, and symptoms related to blood sugar swings like frequent urination and increased thirst. Some functional tumors cause specific symptoms like low blood sugar episodes, severe stomach ulcers, or distinctive skin rashes. Many PNETs cause no symptoms until they grow quite large.

How are pancreatic neuroendocrine tumors diagnosed?

Diagnosis involves multiple approaches including blood tests to check hormone levels, imaging tests like CT scans, MRI, endoscopic ultrasound, and specialized nuclear medicine scans that can detect neuroendocrine tumors specifically. A biopsy, where a small tissue sample is examined under a microscope, confirms the diagnosis and helps determine the tumor grade.

🎯 Key takeaways

  • Pancreatic NETs are fundamentally different from common pancreatic cancer, growing slowly and offering much better survival prospects with 95% five-year survival for localized tumors
  • About 10% of insulinomas and 60% of gastrinomas are cancerous, while glucagonomas are often malignant and require careful monitoring
  • The liver is the most common site for PNET metastases because blood from the pancreas flows directly there through the portal vein
  • Functional tumors that overproduce hormones often get detected earlier due to symptoms, while nonfunctional tumors may grow silently for years before discovery
  • Carcinoid syndrome, causing facial flushing and diarrhea, can be triggered by specific foods like aged cheese, chocolate, and alcohol in some patients
  • Clinical trials offer access to promising new treatments for PNETs, and family members can play a vital role in researching options and providing support during participation
  • Many patients with pancreatic NETs live actively for years with proper treatment, adapting their daily routines while maintaining quality of life
  • CABOMETYX, newly approved in 2025, offers another treatment option for patients whose PNETs have progressed after previous therapy